Lugol's iodine identifies synchronous invasive carcinoma--time for a clinical trial.
Lugol's iodine is currently under investigation as a technique to detect dysplasia, carcinoma in situ and invasive carcinoma at resection margins, plus further afield. Lugol's iodine is inexpensive and easy to use. We present two cases where the technique revealed abnormal mucosa (one carcinoma, one squamous cell carcinoma in situ) at distant sites from the tumour being treated within oral cavity and oropharynx.
Kanatas
A N
AN
Maxillofacial Unit, Bradford Teaching Hospitals NHS Foundation Trust, Bradford BD5 0NA, United Kingdom. a.kanatas@doctors.org.uk
Jenkins
G W
GW
Sutton
D
D
McCaul
J A
JA
D002294:Carcinoma, Squamous Cell / Q000601:surgery*; D005260:Female; D006801:Humans; D008297:Male; D009062:Mouth Neoplasms / Q000601:surgery*; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D009959:Oropharyngeal Neoplasms / Q000601:surgery*